Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-12-10 00:00:00 ET · period of report 2025-12-08 · accession 0001835458-25-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-10 | 2025-12-08 | KNSA | Ragosa Mark | CFO | M - OptEx | $11.34 | +42.8K | 47.2K | +972% | +$486.0K |
| D | 2025-12-10 | 2025-12-08 | KNSA | Ragosa Mark | CFO | S - Sale+OE | $41.49 | -42.8K | 31.1K | -58% | -$1.78M |
| DM | 2025-12-10 | 2025-12-08 | KNSA | Ragosa Mark | CFO | M - OptEx | $0.00 | -42.8K | 5,388 | -89% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-12-08 | M | A | 10,512 | $10.76 | 73,927 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-12-08 | M | A | 16,165 | $11.97 | 63,415 | D | — | — | |
| 3 | Common | Class A Ordinary Share | 2025-12-08 | M | A | 16,164 | $11.10 | 47,250 | D | — | — | |
| 4 | Common | Class A Ordinary Share | 2025-12-08 | S | D | 42,841 | $41.49 | 31,086 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $41.20 and $42.08. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 5 | Derivative | Share Option | 2025-12-08 | M | D | 16,165 | $0.00 | 12,123 | D | $11.97 · — to 2032-08-31 | 16,165 Class A Ordinary Share | (F4) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2022. |
| 6 | Derivative | Share Option | 2025-12-08 | M | D | 10,512 | $0.00 | 14,016 | D | $10.76 · — to 2033-03-31 | 10,512 Class A Ordinary Share | (F5) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2023. |
| 7 | Derivative | Share Option | 2025-12-08 | M | D | 16,164 | $0.00 | 5,388 | D | $11.10 · — to 2032-04-06 | 16,164 Class A Ordinary Share | (F3) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 7, 2022. |